IGF-1 LR3 (long R3 insulin-like growth factor-1)
Muscle & Strength · Modified IGF-1 analog
Tier D
Bottom line
Read Off Label grades IGF-1 LR3 (long R3 insulin-like growth factor-1) as D (2.9/10) based on weak evidence, med benefit magnitude, and a high-risk safety profile.
Used in cell culture research, diverted for performance use.
Typical use: Typical illicit: 20-50 mcg/day subQ — Research chem (not approved); banned sport.
What this is
Used in cell culture research, diverted for performance use. Hypoglycemia is acute and potentially severe. Chronic IGF-1 signaling activation theoretically pro-oncogenic — longevity circles argue for LOWER IGF-1 for lifespan. Counterfeits and underdosed products rampant.
Mechanism
Modified IGF-1 with Arg3 substitution and N-terminal 13-aa extension; drastically reduced IGFBP binding — longer plasma half-life and higher bioavailability than native IGF-1
Dose & route
Typical illicit: 20-50 mcg/day subQ
Citations
- https://pubmed.ncbi.nlm.nih.gov/3288649/
- https://pubmed.ncbi.nlm.nih.gov/15702321/
- https://pubmed.ncbi.nlm.nih.gov/28315373/
Links go to the source. If a link is dead or you want something re-checked, let me know.
Common questions
- Does IGF-1 LR3 (long R3 insulin-like growth factor-1) work?
- Read Off Label rates the evidence for IGF-1 LR3 (long R3 insulin-like growth factor-1) as Weak and the benefit magnitude as med, producing an overall grade of D (2.9/10). Used in cell culture research, diverted for performance use.
- Is IGF-1 LR3 (long R3 insulin-like growth factor-1) safe?
- IGF-1 LR3 (long R3 insulin-like growth factor-1) has a high risk profile in published human data. Legal status: Research chem (not approved); banned sport. This is not medical advice — see the disclaimer.
- What is the typical dose for IGF-1 LR3 (long R3 insulin-like growth factor-1)?
- Typical illicit: 20-50 mcg/day subQ
- How does IGF-1 LR3 (long R3 insulin-like growth factor-1) work?
- Modified IGF-1 with Arg3 substitution and N-terminal 13-aa extension; drastically reduced IGFBP binding — longer plasma half-life and higher bioavailability than native IGF-1
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.